Form 4: Humana Director Boosts Stake with Deferred Stock Units

Humana Director Kurt J. Hilzinger acquired additional restricted stock units through annual fees, dividend reinvestment, and cash fee conversion, deferring payout until resignation.

Summary

• Humana Inc. Director Kurt J. Hilzinger reported the acquisition of 1,734 Restricted Stock Units (RSUs) across three separate transactions.
• The acquisitions include 766 RSUs from an annual director's fee, 611 RSUs from dividend reinvestment, and 357 RSUs from a cash fee conversion.
• All acquired RSUs are deferred at the election of Mr. Hilzinger and will be payable in Humana Inc. common stock on a 1-for-1 basis upon his resignation as a director.
• The 766 RSUs were acquired at a price of $0, representing an annual director's fee.
• The 611 and 357 RSUs were acquired at a price of $258.8675 per unit.
• Following these transactions, Mr. Hilzinger beneficially owns 19,448 shares of Humana Common Stock directly, and various tranches of Restricted Stock Units totaling 24,800, 3,364, and 15,765 units respectively.

Sentiment

Score: 6

Explanation: The filing indicates routine director compensation and reinvestment activities, which are generally positive for aligning director interests with shareholders but not a significant market-moving event. The deferral mechanism is a standard practice.

Positives

• A director increasing their beneficial ownership, even through compensation, generally signals confidence in the company's future performance and aligns their interests with shareholders.
• The deferral of stock unit payouts until resignation encourages long-term commitment and strategic oversight from the director.

Future Outlook

The acquired Restricted Stock Units are deferred and will be paid out in Humana Inc. common stock on a 1-for-1 basis upon the reporting person's resignation of services as a director.

Management Comments

• Annual Director's fee payable in stock units has been deferred at the election of the Reporting Person until his resignation of services as a director, at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Director's dividend payment was reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director, at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Director's cash fee was elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions, with stock units payable in Humana Inc. common stock on a 1-for-1 basis upon resignation.

Industry Context

Director compensation in the form of restricted stock units, with deferral options, is a common practice in the healthcare and insurance industry, aligning executive and director incentives with long-term shareholder value creation. This filing reflects standard corporate governance practices for a large publicly traded company like Humana.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of director compensation is a standard practice among S&P 500 companies, including those in the healthcare sector, to align director interests with long-term company performance.
• The option for directors to defer the receipt of stock units until resignation is also a common corporate governance feature, often seen in companies like UnitedHealth Group (UNH) or CVS Health (CVS), which operate in similar or related healthcare services and insurance markets, promoting sustained engagement and tax efficiency for the director.

Corporate Governance

Related Party Transactions

• The reported transactions are related party dealings as they involve a director of Humana Inc. acquiring company securities as part of their compensation and investment choices.

Stakeholder Impact

• Shareholders: The increase in director's beneficial ownership, even through compensation, can be viewed positively as it aligns the director's financial interests with the long-term performance of the company, potentially fostering more shareholder-friendly decisions.

Next Steps

• The Restricted Stock Units will be paid out in Humana Inc. common stock on a 1-for-1 basis upon Kurt J. Hilzinger's resignation as a director.

Key Dates

Keywords

Humana, HUM, SEC Form 4, Insider Transaction, Restricted Stock Units, Director Compensation, Beneficial Ownership, Stock Units, Healthcare, Insurance